v3.26.1
Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2026
Net Loss Per Share [Abstract]  
Schedule of Basic and Diluted Net Loss Per Share

The components of basic and diluted net income (loss) per share were as follows:

 

   Three months ended
March 31,
 
(In thousands, except share and per share data)  2026   2025 
Numerator:        
Net income (loss) from continuing operations  $19,922   $(3,274)
Net income from discontinued operations   
    1,648 
Minus: net income allocated to participating warrants   (16,641)   
 
Numerator for basic EPS - Net income (loss) available for common shareholders  $3,281   $(1,626)
           
Effect of dilutive securities          
Interest expense on Convertible Notes - from continuing operations  $1,480   $
 
Reallocation of net income to participating warrants   2,214    
 
Numerator for diluted EPS - Net income (loss) available for common shareholders  $6,975   $(1,626)
           
Denominator:          
Denominator for basic EPS - Weighted-average common shares outstanding   2,149,128    1,952,022 
Effect of dilutive securities          
Unvested restricted stock units   126,750    
 
Conversion of Convertible Notes   2,971,433    
 
Denominator for diluted EPS - adjusted weighted-average common stock outstanding   5,247,311    1,952,022 
Basic net income (loss) per share attributable to common shareholders  $1.53   $(0.83)
Diluted net income (loss) per share attributable to common shareholders  $1.33   $(0.83)
Schedule of Anti-Dilutive Shares

The Company excluded the following potential common stock equivalents, based on amounts outstanding at each period end, from the computation of diluted earnings (loss) per share attributable to common stockholders for the periods presented because their inclusion would have been antidilutive. In addition, the Company’s pre-funded warrants are considered participating securities and are reflected through the application of the two-class method; accordingly, they are not included in the diluted earnings per share denominator in periods in which the two-class method results in the most dilutive outcome.

 

   Three months ended
March 31,
 
   2026   2025 
Shares subject to outstanding warrants   11,034,325    7,576,573 
Shares subject to unvested restricted stock units   
    102,132 
Shares subject to outstanding stock options   75    90 
    11,034,400    7,678,795